A Smart DNA Network-Based Diagnostic System for Enrichment and Detection of Circulating Tumor Cells in Cancer Liquid Biopsy
Analytical Chemistry · 2025
DOI: 10.1021/acs.analchem.5c00648 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Jing Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Synthetic Biology, Frontiers Science Center for Synthetic Biology, Key Laboratory of Systems Bioengineering (MOE), School of …. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Breast Neoplasms, DNA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Circulating tumor cells (CTCs) have emerged as critical biomarkers in liquid biopsy for noninvasive tumor diagnosis and real-time monitoring of cancer progression. However, the isolation of CTCs is often required before detection due to their ultralow abundance in peripheral blood. These isolation processes are typically time-consuming and prone to cell loss, which limits the utility of CTC-based liquid biopsy. Herein, we present a DNA network-based diagnostic system that enables specific recognition, selective enrichment, and accurate detection of CTCs directly from blood samples. The DNA network comprises ultralong DNA chains embedded with polyvalent aptamers and fluorescence detection modules. The polyvalent aptamers selectively bind to the epithelial cell adhesion molecule (EpCAM) on a CTC membrane, facilitating their enrichment through base pairing-driven DNA network formation. This system semiquantitatively detects the expression level of cancer-associated microRNA within CTCs using ratiometric fluorescence imaging based on the chemical assembly of two fluorescence modules. In clinical blood samples, this diagnostic system achieves 100% precision and 96% accuracy in distinguishing breast cancer patients from healthy donors, highlighting its promising potential for clinical breast cancer diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Synthetic Biology, Frontiers Science Center for Synthetic Biology, Key Laboratory of Systems Bioengineering (MOE), School of Chemical Engineering and Technology, Tianjin University, Tianjin 30035…
- Department of Chemistry, State Key Laboratory of Molecular Engineering of Polymers, Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, College of Chemistry and Materials, Fudan University, Shanghai…
- Department of Gastric Surgery, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Tianjin Medical University Cancer Institute and Hos…
ORCID-Profile: Dayong Yang, Chi Yao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, J., Tang, J., Liang, A., Cui, Z., Huo, J., Li, Q., Ke, B., Yang, D., & Yao, C. (2025). A Smart DNA Network-Based Diagnostic System for Enrichment and Detection of Circulating Tumor Cells in Cancer Liquid Biopsy. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c00648
Vancouver
Wang J, Tang J, Liang A, Cui Z, Huo J, Li Q, et al. A Smart DNA Network-Based Diagnostic System for Enrichment and Detection of Circulating Tumor Cells in Cancer Liquid Biopsy. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.5c00648
BibTeX
@article{Wang2025,
author = {Wang, Jing and Tang, Jianpu and Liang, Aiqi and Cui, Zhen and Huo, Jiale and Li, Qian and Ke, Bin and Yang, Dayong and Yao, Chi},
title = {A Smart DNA Network-Based Diagnostic System for Enrichment and Detection of Circulating Tumor Cells in Cancer Liquid Biopsy},
journal = {Analytical Chemistry},
year = {2025},
doi = {10.1021/acs.analchem.5c00648}
}
EUVIMED